Literature DB >> 2445814

Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.

F Levi-Schaffer1, E T Dayton, K F Austen, A Hein, J P Caulfield, P M Gravallese, F T Liu, R L Stevens.   

Abstract

Mouse bone marrow-derived mast cells (BMMC), cultured for 2, 7, or 14 days in WEHI-3 conditioned medium in the absence or presence of mouse 3T3 fibroblasts, were examined morphologically and for their functional responses to IgE-Fc-mediated and calcium ionophore-mediated activation. The 7- and 14-day fibroblast-adherent and non-fibroblast-adherent populations of cocultured BMMC had more granules per cell and the granule contents were more electron dense than non-cocultured BMMC or BMMC cocultured for only 2 days. The adherent cocultured BMMC were usually located within multiple layers of fibroblasts, but did not form junctions with the fibroblasts. When activated immunologically, the adherent cocultured mast cells generally discharged their granules singly, but compound exocytosis was occasionally seen. Both the non-adherent cocultured BMMC and the BMMC that were cultured in the absence of fibroblasts were similar to one another in that they exocytosed 9 to 11% of their histamine when sensitized with anti-dinitrophenyl IgE and challenged with dinitrophenyl-bovine serum albumin and 27 to 29% of their histamine when challenged with calcium ionophore. In contrast, adherent cocultured BMMC exocytosed 27 and 61% of their histamine upon immunologic and calcium ionophore activation, respectively, representing a significant two- to three-fold increase relative to that obtained from the other populations of BMMC. When activated immunologically, BMMC cultured in WEHI-3 conditioned medium alone generated a mean of 12 ng of immunoreactive C-6-sulfidopeptide leukotrienes, 1.6 ng of leukotriene B4 (LTB4), and 1.0 ng of prostaglandin D2 (PGD2)/10(6) cells. The immunologic response of the nonadherent 7-day cocultured BMMC was similar. Fibroblast-adherent cocultured BMMC, on the other hand, generated 56 ng of immunoreactive C-6-sulfidopeptide leukotrienes, 6.4 ng of LTB4, and 5.6 ng of PGD2/10(6) mast cells, representing a significant increase for each product. When calcium ionophore was used as the agonist, the adherent cocultured mast cells also generated significantly more arachidonic acid metabolites than nonadherent cocultured BMMC or BMMC cultured in the absence of fibroblasts. Retention times on high performance liquid chromatography confirmed that the generated immunoreactive products were LTB4, PGD2, and LTC4. Thus, coculture of BMMC with fibroblasts induces an alteration in the composition of the secretory granules of the mast cells, as well as an augmentation of the activation-secretion response of the BMMC.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445814

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Deficient eosinophil chemotaxis-promoting activity of genetically normal mast cells transplanted into subcutaneous tissue of Mitfmi-vga9/Mitfmi-vga9 mice: comparison of the activity and mast cell distribution pattern with KitW/KitW-vMice.

Authors:  Keisuke Oboki; Eiichi Morii; Yukihiko Kitamura
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

2.  Update on Eosinophil Interaction with Mast Cells: The Allergic Effector Unit.

Authors:  Roopesh Singh Gangwar; Hadas Pahima; Pier Giorgio Puzzovio; Francesca Levi-Schaffer
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Mast cell modulation of the vascular and lymphatic endothelium.

Authors:  Christian A Kunder; Ashley L St John; Soman N Abraham
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

4.  Macrophage functions are regulated by the substratum of murine decidual stromal cells.

Authors:  R W Redline; D B McKay; M A Vazquez; V E Papaioannou; C Y Lu
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 5.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

6.  The transcription factors GATA2 and microphthalmia-associated transcription factor regulate Hdc gene expression in mast cells and are required for IgE/mast cell-mediated anaphylaxis.

Authors:  Yapeng Li; Bing Liu; Laura Harmacek; Zijie Long; Jinyi Liang; Kara Lukin; Sonia M Leach; Brian O'Connor; Anthony N Gerber; James Hagman; Axel Roers; Fred D Finkelman; Hua Huang
Journal:  J Allergy Clin Immunol       Date:  2017-12-24       Impact factor: 10.793

7.  Rat bone marrow-derived mast cells co-cultured with 3T3 fibroblasts in the absence of T-cell derived cytokines require stem cell factor for their survival and maintain their mucosal mast cell-like phenotype.

Authors:  A J MacDonald; E M Thornton; G F Newlands; S J Galli; R Moqbel; H R Miller
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

Review 8.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

9.  Granule proteinases define mast cell heterogeneity in the serosa and the gastrointestinal mucosa of the mouse.

Authors:  H R Miller; J F Huntley; G F Newlands; A Mackellar; D A Lammas; D Wakelin
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

10.  The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II.

Authors:  Jian Gong; Ning-Sun Yang; Michael Croft; I-Chun Weng; Liangwu Sun; Fu-Tong Liu; Swey-Shen Chen
Journal:  BMC Immunol       Date:  2010-06-30       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.